Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
2.63B | 2.17B | 1.73B | 1.30B | 883.03M | Gross Profit |
2.23B | 1.82B | 1.42B | 1.04B | 716.07M | EBIT |
-67.60M | -208.06M | -109.10M | -43.54M | -50.83M | EBITDA |
129.23M | -81.23M | -38.53M | -228.00K | -4.57M | Net Income Common Stockholders |
4.63M | -176.29M | -112.75M | -77.84M | -85.03M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
2.07B | 1.39B | 1.41B | 1.20B | 1.25B | Total Assets |
3.80B | 3.07B | 2.54B | 2.17B | 1.97B | Total Debt |
745.42M | 787.81M | 806.34M | 712.97M | 788.62M | Net Debt |
232.75M | 399.83M | 475.32M | 335.95M | 410.50M | Total Liabilities |
1.89B | 1.75B | 1.55B | 1.30B | 1.21B | Stockholders Equity |
1.91B | 1.32B | 992.22M | 873.80M | 762.65M |
Cash Flow | Free Cash Flow | |||
560.66M | 250.72M | 181.40M | 176.86M | 30.04M | Operating Cash Flow |
598.60M | 350.97M | 273.17M | 238.73M | 88.91M | Investing Cash Flow |
-515.86M | -334.77M | -319.66M | -179.51M | -215.57M | Financing Cash Flow |
53.49M | 37.01M | 7.43M | -51.47M | 222.46M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $11.72B | 53.41 | 24.39% | 0.65% | 10.15% | -28.62% | |
68 Neutral | $4.07B | ― | -1.66% | ― | 15.72% | 74.59% | |
67 Neutral | $26.15B | 5,844.99 | 0.29% | ― | 21.07% | ― | |
66 Neutral | $2.77B | 19.81 | 45.56% | ― | 10.74% | 200.08% | |
63 Neutral | $3.71B | ― | -8.63% | ― | 20.79% | 32.50% | |
58 Neutral | $1.17B | ― | -39.88% | ― | 21.66% | 8.66% | |
57 Neutral | $18.52B | 9.81 | -13.96% | 2.71% | 5.07% | -23.65% |
HubSpot, Inc. announced the resignation of Chief Legal Officer Alyssa Harvey Dawson, effective December 31, 2024, by mutual agreement with the Board. During a transition period until March 2025, Dawson will continue to receive her salary, equity vesting, and benefits. Post-transition, she will receive severance and COBRA reimbursement. This change is amicable, with no operational disagreements cited.